Совершенствование системы оказания специализированной помощи пациентам с хронической сердечной недостаточностью в республике Башкортостан
Диссертация
Длительная терапия неселективным Р-адреноблокатором карведи-лолом приводит к более значимому улучшению систолической и диастоли-ческой функции сердца и повышению фракции выброса левого желудочка, коррекции дисфункции эндотелия за счет значимого снижения уровня эндо-телина-1 в плазме крови и повышения эндотелийзависимой вазодилатации, стабилизации состояния системы гемостаза, сопровождающейся… Читать ещё >
Список литературы
- Аульченко Ю.С., Аксенович Т. И. Методологические подходы и стратегии картирования генов, контролирующих комплексные признаки человека // Вестник ВОГИС. 2006. — Т. 10, № 1. — С. 189−202.
- Баранов B.C., Баранова Е. В., Иващенко Т. Е. и др. Геном человека и «гены предрасположенности». Введение в предиктивную медицину. Санкт-Петербург «Интермедика». — 2000.
- Беленков Ю.Н., Мареев В. Ю. Сердечно-сосудистый континуум // Журнал Сердечная недостаточность. 2002. — Т. 3, № 1. — С. 7—11.
- Беленков Ю.Н., Мареев В. Ю., Агеев Ф. Т. Хроническая сердечная недостаточность. Избранные лекции по кардиологии. // Москва. Издательская группа «Гэотар-медиа». 2006. -С. 432.
- Белов Ю.В., Вараксин В. А. Постинфарктное ремоделирование левого желудочка сердца. От концепции к хирургическому лечению // Москва. Издательство «Де ново». 2002. — С. 194.
- Белова JI. А. Ангиотензин П-образующие ферменты // Биохимия -2000. Т. 65, № 12. — С. 1589−1599.
- Васюк Ю.А. Возможности и ограничения эхокардиографического исследования в оценке ремоделирования левого желудочка при ХСН // Журнал Сердечная недостаточность. 2003. — Т. 4, № 2. — С.107−110.
- Гланц С. Медико-биологическая статистика // Москва. Издательство «Практика». 1999. — С. 459.
- Гомазков О. А. Пептиды в кардиологии. Биохимия. Физиология. Патология. Информация. Анализ // Москва. Издательство «Материк Альфа». — 2000. С. 143.
- Григорьева Е.В. Молекулярно-генетическое исследование инфаркта миокарда в популяции якутов // Диссертация на соискание ученойстепени кандидата мед наук. Институт биохимии и генетики УНЦ РАН. Уфа. 2006.
- Гуревич М.А. Хроническая сердечная недостаточность. Руководство для врачей // Москва. ООО «Медицинское информационное агентство». 2005. — С. 280.
- Елисеева Ю.Е. Ангиотензин-превращающий фермент, его физиологическая роль // Вопросы медицинской химии. 2001. — 1.
- Животовский, JI.A. Популяционая биометрия // Москва. Наука -1991.-С. 272.
- Журавлева И.А., Мелентьев И. А., Виноградов H.A. Роль окиси азота в кардиологии и гастроэнтерологии // Клиническая медицина. -1997.-Т. 75, № 4.-С. 18−21.
- Зиц C.B. Диагностика и лечение застойной сердечной недостаточности // Москва. Издательство «Медпресс». — 2000. — С. 128.
- Камышников B.C., Пристром М. С., Штонда М. В. Особенности показателей липидного обмена у больных ИБС осложненной хронической сердечной недостаточностью // Форум Кардиология 2003. (сборник тезисов).
- Комисаренко В.П., Минченко А. Г., Тронько Н. Д. Молекулярные механизмы действия стероидных гормонов // Киев «Здоров'я». 1986. — С. 192.
- Мазур В.В., Мазур Е. С., Пун Ч.Б Особенности постинфарктного ремоделирования левого желудочка сердца у больных артериальной гипертонией // Кардиология. 2004. -7. — С. 53−56.
- Малая JI.T. Горб Ю. Г. Хроническая сердечная недостаточность: Новейший справочник // Москва. — 2004. — С. 960.
- Маниатис Т., Фрич Э., Сэмбрук Дж. Методы генетической инженерии. Молекулярное клонирование // Москва. Мир. — 1984. — С. 399.
- Мареев В. Ю. Фомин И.В. Агеев Ф. Т. и др. Распространенность факторов риска среди больных артериальной гипертонией в Европейской части Российской федерации// Журнал Сердечная недостаточность. 2004. -Т. 5, № 6. — С. 282−284.
- Маркель A. JL, Якобсон Г. С. Генетика гипертензивных состояний человека: ренин-ангиотензин-альдостероновая система // Вестник РАМН. -1997.-7.-С. 59−66.
- Насибуллин Т.Р. Особенности генетической конституции у больных эссенциальной по полиморфным ДНК-локусам // Автореферат на соискание ученой степени кандидата медицинских наук// 14.00.06. 03.00.15. -Уфа.-2002.
- Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (третий пересмотр), http://medic.ossn.ru/upload/ossnpdf/ Reco-mend/Guidelines%20SSHF%20rev.3.01%202 010.pdf.
- Обрезан А. Г. Вологодина И.В. Хроническая сердечная недостаточность // Санкт-Петербург. Издательство «Вита Нова». — 2002. — С. 320.
- Ольбинская JT.И., Сизова Ж. М. Хроническая сердечная недостаточность // Москва. Реафарм. 2001. -С. 344.
- Пузырев К.В. Клинико-генетическое исследование факторов предрасположенности к эссенциальной гипертензии и идиопатической кардио-миопатии // Автореферат на соискание ученой степени кандидата медицинских наук// 14.00.16- 03.00.15. Томск. — 1999.
- Реброва О.Ю. Статистический анализ медицинских данных. Применение пакета прикладных программ Statistica // Москва. Издательство «Медиа Сфера». 2002. — С. 312.
- Романова Т.А., Петрова И. Р., Горошко Н. М., и др. Гены-кандидаты, ассоциированные с ишемической болезнью сердца: сравнительный анализ якутской и московской популяциях // Тезисы Российского национального конгресса кардиологов. Москва. — 2003. — С. 273.
- Романова Т. А. Петрова И.Р. Минушкина Л. О. и др. Генетические маркеры атеросклероза коронарных артерий у больных ИБС жителей Якутии // Тезисы Российского национального конгресса кардиологов — Томск.-2004.-С. 419.
- Флоря В.Г. Роль ремоделирования левого желудочка в патогенезе хронической сердечной недостаточности кровообращения // Кардиология. -1997.-№ 5. -С. 63−70.
- Фомин И.В., Беленков Ю. Н., Мареев В. Ю., Агеев Ф.Т.,
- ОССН Распространенность хронической сердечной недостаточности в Европейской части Российской Федерации — данные ЭПОХА—ХСН // Сердечная Недостаточность. 2006. — Т. 7, № 3. — С. 112−115.
- Чистяков Д.А., Кобалава Ж. Д., Терещенко С. Н. и др. Полиморфизм гена сосудистого рецептора ангиотензина II и сердечно-сосудистые заболевания // Терапевтический архив. 2000. — № 4. — С. 27−30.
- Чистяков Д.А., Чугунова JI.A., Шамхалова М. Ш. и др. Полиморфизм гена сосудистого рецептора ангиотензина II и микроангиопатии при ин-сулинзависимом сахарном диабете // Генетика. — 1999. — Т. 35, № 9. — С.1289−1293.
- Abdollahi М. R., Gaunt T.R., Syddall Н.Е. et al. Angiotensin II type1 receptor gene polymorphism: anthropometric and metabolic syndrome traits // Journal of Medical Genetics 2005. — № 42. — P. 396—401.
- Akar N., Akar E., Cin S. et al. Endothelial nitric oxide synthase intron 4, 27-bp repeat polymorphism in Turkish patients with deep vein thrombosis and cerebrovascular accidents // Thrombosis Research. 1999. — № 94. — P. 63−64.
- Amant C., Hamon M., Bauters C. et al. The angiotensin II type 1 receptor gene polymorphism is associated with coronary artery vasoconstriction // Journal of the American College of Cardiology. 1997. — № 29. — P. 486−490.
- Anand I.S., Ferrari R., Kalra G.S. et al. Edema of cardiac origin: studies of body water and sodium, renal function, hemodynamic indexes, and plasma hormones in untreated congestive heart failure // Circulation. 1989. — 80. -P.299−305.
- Andersson В., Blange’I., Sylven Ch. Angiotensin-II type 1 receptor gene polymorphism and long-term survival in patients with idiopathic congestive heart failure // European Journal of Heart Failure 1999. — V. 1, № 4. — P. 363−369.
- Andersson В., Sylven Ch. The DD genotype of the angiotensin-converting enzyme gene is associated with increased mortality in idiopathicheart failure // Journal of the American College of Cardiology. 1996. — V. 28, № l.-P. 162−167.
- Arakawa K., Urata H. Hypothesis regarding the pathophysiologycal role of alternative pathways of agiotension II formation in atherosclerosis // Hypertension. 2000. — V. 33. — P. 638−641.
- Ashavaid T.F., Shalia K.K., Nair K.G. et al. ACE and AT1R gene polymorphisms and hypertension in Indian population // J. Clin. Lab. Anal. -2000.-V 14.-P. 230−237.
- Barden A.E., Herbison C.E., Beilin L.J. et al. Association between the endothelin-1 gene Lysl98Asn polymorphism blood pressure and plasma endothe-lin-1 levels in normal and pre-eclamptic pregnancy // J. Hypertens. 2001. -V. 19.-P. 1775−1782.
- Baudin B. Polymorphism in angiotensin II receptor genes and hypertension // Experimental Physiology. 2005. — V. 90, № 3. — P. 277−282.
- Benetos A., Cambien F., Gautier S. et al. Influence of angiotensin II type 1 receptor polymorphism on the effects of perindopril and nitrendipine on arterial stiffness in hypertensive individuals // Hypertension. 1996. — V. 28. -P. 1081−1084.
- Bishop T. Sham P. Analysis of multifactorial disease // BIOS ltd. -2000.-P. 345.
- Bonnardeaux A., Davies E., Jeunmaitre X. et al. Angiotensin II type 1 receptor gene polymorphism in human essential hypertension // Hypertension. -1994.-V. 24.-P. 63−69.
- Bonvalet J.P., Regulation of sodium transport by steroid hormone // Kidney Int. 1998. — V. 53. — 549−556.
- Brand E., Chatelain N., Mulatero P. et al. Structural analysis and evaluation of the aldosterone synthase gene in hypertension // Hypertension -1998.-V. 32.-P. 198−204.
- Braunwald E, Bristow M.R. Congestive Heart Failure: Fifty years of progress // Circulation. 2000. — V. 102. — IV14-IV23.
- Braunwald E. Congestive heart failure: a half century perspective // European Heart Journal 2001. V. 22. — P. 825−836.
- Brilla C.G., Weber K.T. Mineralcorticoid excess, dietary sodium and myocardial fibrosis // J Lab Clin Med 1992 — V. 120 — P. 893−901.
- Buraczynska M., Ksiazek P., Zaluska W. et al. Endothelial nitric oxide synthase gene intron 4 polymorphism in patients with end-stage renal disease // Nephrol Dial Transplant. 2004. — V. 19. — P. 2302−2306.
- Cabrera C., Bohr D. // Biochem. Biophys. Res. Commun. 1995. -V. 206.-P. 77−81.
- Cacoub P, Dorent R., Nataf P et al. Endothelin 1 in the lungs of patients with pulmonary hypertension // Cardiovasc Res. — 1997. — V. 33, № 1. — P. 196−200.
- Cambien F., Alhenc-Gelas F., Herbeth B. et al. Familial resemblance of plasma angiotensin-converting enzyme level- the Nancy study // Am. J. Hum. Genet. 1988. — V. 43. — P. 774−780.
- Cambien F., Costerousse O., Tiret L. et al. Plasma Level and Gene Polymorphism of Angiotensin-Converting Enzyme in Relation to Myocardial Infarction // Circulation 1994. — V. 90. — P. 69−676.
- Cambien F., Poirier O., Lecerf L. et al. Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction //Nature. 1992. — V. 359. — P. 641−644.
- Cameron V.A., Mocatta T.J., Pilbrow A.P. et al. Angiotensin type-1 receptor A1166C gene polymorphism correlates with oxidative stress levels in human heart failure // Hypertension. 2006. — V. 47. — P. 1155−1161.
- Carluccio M., Soccio M., De Caterina R. Aspects of gene polymorphisms in cardiovascular disease: the renin-angiotensin system // European journal of Clinical investigation. 2001. — V. 31. — P. 476−488.
- Casas J.P., Bautista L.E., Humphries S.E. et al. Endothelial nitric oxide synthase genotype and ischemic heart disease. Meta-analysis of 26 studies involving 23 028 patients // Circulation. 2004. — V. 109. — P. 1359−1365.
- Caughey G.H., Schaumberg T.H., Zerwek E.H. et al. The human mast cell chymase gene (CMA1): mapping to the cathepsin G/granzyme gene cluster and lineage restricted expression // Genomics. 1993. — V. 17. — P. 614−620.
- Celentano A., Mancini F.P., Crivaro M. et al. Influence of cardiovascular risk factors on relation between angiotensin converting enzyme-gene polymorphism and blood pressure in arterial hypertension // J. Hypertens. 1998 -V. 16.-№ 7.-P. 985−991.
- Charbit M., Blazy I., Gogusev J. et al. Nitric oxide and the renin angiotensin system: contributions to blood pressure in the young rat // Pe-diatr.Nephrol. 1997. — V. 11, № 5. — P. 617−622.
- Chen A., Zhang W., Tang X. et al. The relationship of aldosterone synthase gene polymorphism with hypertension and left ventricular hypertrophy // Article in Chinese. 2002. — V. 41, № 5. — P. 298−301.
- Clifford C.P., Nunez D.J.R. Racial differences in the frequency of restriction site polymorphism of the angiotensin converting enzyme (ACE) gene
- Abstract 16th Sei. Meeting Internat Soc. Hypertension. Glasgow, UK, 1996. 4B.3.1598.
- Conway MA, Bottomley PA, Ouwerkerk R. et al. Mitral regurgitation: impaired systolic function, — eccentric hypertrophy, and increased severity are linked to low phosphocreatine/ATP ratios in humans // Circulation. 1998. -V. 97.-P. 1716−1723.
- Crisan D., Carr J. Angiotensin I-Converting Enzyme. Genotype and Disease // Associations Journal of Molecular Diagnostics. 2000. — V. 2, № 3. — P. 105−115.
- Dai S.M., Shan Z.Z., Miao C.Y. et al. Hemodynamic responses to endothelin 1 and endothelin antagonists micro injected into the nucles tractus soli-tarius in rats // J. Cardiovasc Pharmacol. — 1997. — V. 30, № 4. — P. 475−480.
- Delcayre C., Swynghedauw B. Molecular mechanisms of myocardial remodeling. The role of adosterone // J. Mol. Cell. Cardiol. 2002. — V. 34 -P. 1577−1584.
- Delies Ch., Erdmann J., Jacobi J. et al. Aldosterone synthase (CYP11B2) -344 C/T polymorphism is associated with left ventricular structure in human arterial hypertension // J. Am. Coll. Cardiol. 2001. — V. 37. -P. 878−884.
- Diet F., Graf C., Mahnke N. et al. ACE and angiotensinogen gene genotypes and left ventricular mass in athletes // European Journal of Clinical Investigation. 2001. — V. 31. — P. 836−842.
- Doering C.W., Jalil J.E., Janicki J.S. et al. Collagen network remodeling and diastolic stiffness of the rat left ventricle with pressure overload hypertrophy // Cardiovasc Res. 1988. — V. 22. — P. 686−695.
- Droma Y., Hanaoka M., Ota M. et al. Positive association of the endothelial nitric oxide synthase gene polymorphisms with high-altitude pulmonary edema // Circulation. 2002. — V. 106. — P. 826−830.
- Du Bois D., Du Bois E.F. A formula to estimate the approximate surface area if height and weight be known // Arch Intern Med. 1976. — V. 17-P. 863−71.
- Duncan J.A., Scholey J.W., Miller J.A. Angiotensin II type 1 receptor gene polymorphisms in humans: physiology and pathophysiology of the genotypes // Curr. Opin. Nephrol. Hypertens. 2001. — V 10, № 1. — P. 111−116.
- Dura K., Farrow S., Wang J-M. et al. Frequency of a deletion polymorphism in gene for angiotensin converting enzyme is increased in African-Americans with hypertension // Am. J. Hypertens. 1994. — V. 7. — P. 759−762.
- Fernandez-Areas N., Dieguez-Lucena J.L., Munoz-Moran E et al. The genotype interactions of methylenetetrahydrofolate reductase and renin-angiotensin system genes are associated with myocardial infarction // Atherosclerosis 1999. — V. 145. — P. 293−300.
- Fernandez-Sola J., Nicolas J. M., Oriola J. et al. Angiotensin-converting enzyme gene polymorphism is associated with vulnerability to alcoholic cardiomyopathy // Annals of Internal Medicine. 2002. — V. 137(5 Pt 1). -P. 321−326.
- Forstermann U., Closs E.I., Pollock J.S. et al. Nitric oxide synthase isozymes, characterization, purification, molecular cloning and function // Hypertension. 1994. -V. 23 — P. 1121−1131.
- Treiber F., Barbeau P., Harshfield G. Endothelin-1 gene lysl98asn polymorphism and blood pressure reactivity // Hypertension. 2003. — V. 42. -P. 494−499.
- Friedl W., Krempler F., Paulweber B. et al. A detection polymorphism in the angiotensin converting enzyme gene is not associated with coronary heart disease in an Austrian population // Atherosclerosis. 1995. — V. 112. -P.137−143.
- Fukami H., Okunishi H., Miyazaki M. Chymase: it’s pathological roles and inhibitors // Current Pharmaceutical Design. 1998. — V. 4. — P. 439−453.
- Gardemann A., Harnami M., Katz N. The chyrnase A (-1903)G gene polymorphism is not associated with the risk and extent of coronary heart disease // Atherosclerosis. 2000. — V. 150. — P.445−446.
- Gariepy C.E., Ohuchi T., Williams S.C. Salt-sensitive hypertension in endo-thelin-B receptor-deficient rats // J. Clin. Invest. 2000. — V. 105. — P. 925−933.
- Ghosh S., Collins F.S. The geneticist’s approach to complex disease // Annu. Rev. Med. 1996. — V. 47. — P. 333−353.
- Giard A. Nitric oxide and endothelin 1 in pulmonary hypertension // Chest. — 1998. — V. 144 (3Suppl). — S. 208-S212.
- Giner V., Poch E., Bragulat E. et al. Renin-angiotensin system genetic polymorphisms and salt sensitivity in essential hypertension // Hypertension -2000. V. 35, № 2. — P. 512−517.
- Gomma A. H., Elrayess M. A., Knight C. J. The endothelial nitric oxide synthase (Glu298Asp and -786T>C) gene polymorphisms are associated with coronary in-stent restenosis // Eur. Heart J. 2002. — V. 23. — P. 1955−1962.
- Gunthtie G.PJr. Angiotensin receptors: Physiology and pharmacology // Clin. Cardiology. 1995. -V. 8. — P. III-29-III-34.
- Harrap S.B., Tzourio C., Cambien F. et al.- for the PROGRESS Collaborative Group. The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition // Hypertension -2003.-V. 42-P. 297−303.
- Hasenfuss G., Schillinger W., Lehnart S.E. et al. Relationship between Na±Ca2+ exchanger protein levels and diastolic dysfunction of failing human myocardium // Circulation. 1999. — V. 99. — P. 641−648.
- Hatakeyama H., Miyamori I., Fujita T. et al. Vascular aldosterone. Biosynthesis and a link to angiotensin II induced hypertrophy of vascular smooth muscle cells // J. Biol. Chem. 1994. — V. 269. — P. 24 316−24 320.
- Hautanen A., Toivanen P., Manttari M. et al. Joint efects of an aldosterone synthase (CYP11B2) gene polymorphism and classic risk factors on risk of myocardial infarction // Circulation. 1999. — V. 100. — P. 2213−2218.
- Hein S., Kistin S., Heling A. et. al. The role of the cytoskeleton in heart failure // Cardiovasc. Res. 2000. — V. 45. — P. 272−278.
- Hengstenberg Ch., Holmer S. R., Mayer B. et al. Evaluation of the aldosterone synthase (CYP11B2) gene polymorphism in patients with myocardial infarction // Hypertension. 2000. — V. 35. — P. 704−709.
- Herrmann S.M., Schmidt-Petersen K., Pfeifer J. et al. A polymorphism in the endothelin-A receptor gene predicts survival in patients with idiopathic dilated cardiomyopathy // European Heart Journal. — 2001. — V. 22. -P. 1948−1953.
- Hindorff L.A., Heckbert S.R., Tracy R. et al. Angiotensin II type 1 receptor polymorphisms in the cardiovascular health study: relation to blood pressure, ethnicity, and cardiovascular events // Am. J. Hypertens. 2002. -V. 15.-P. 1050−1056.
- Hingorani A.D., Jia H., Stevens P.A. et al. Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition // J. Hypertens. — 1995. V. 13. — P. 1602−1609.
- Hingorani A.D., Liang C.F., Fatibene J. et al. A common variant of the endothelial nitric oxide synthase (Glu298.Asp) is a major risk factor for coronary artery disease in the UK // Circulation. 1999. — V.100. — P. 1515−20.
- Hocher B., George I, Rebstock J et al. Endothelin sysem-dependent cardiac remodeling in hypertension // Hypertension. 1999. — V. 33, № 3. -P. 816−822.
- Hou L., Osei-Hyiaman D. et al. Association of a 27-bp repeat polymorphism in ecNOS gene with ischemic stroke in Chinese patients // Neurology. -2001.-V. 56.-P. 490−496.
- Huang W., Xie C., Zhou H. et al. Association of the angiotensin-converting enzyme gene polymorphism with chronic heart failure in Chinese Han patients // Eur. J. Heart Fail. 2004. — V. 6, № 1. — P. 23−27.
- Hubert C., Houot A.M., Corvol P. et al. Structure of the angiotensin-converting enzyme gene. Two alternate promoters correspond to evolutionary steps of a duplicated gene // J. Biol. Chem. 1991. -V. 266. — P. 15 377−15 383.
- Iemitsu M., Maeda S, Otsuki T. et al. Polymorphism in endothelin-related genes limits exercise-induced decreases in arterial stiffness in older Subjects // Hypertension 2006. — V 47. — P. 928−936.
- Iglarz M., Benessiano J., Philip I. et al. Preproendothelin-1 gene polymorphism is related to a change in vascular reactivity in the human mammary artery in vitro // Hypertension. 2002. — V. 39. — P. 209−213.
- Ikeda U., Kanbe T., Nakayama I. et al. Aldosterone inhibits nitric oxide synthesis in rat vascular smooth vascular cells induced by interleukin-lb // Eur. J. Pharmacol. 1995. — V. 290. — P. 69−73.
- Innis, M.A. PCR protocols // N. Y. Academic Press. 1990. — P. 3−12.
- Ishihara S., Yamada Y., Fujimura T., Yokota M. Association of polymorphism of the endothelial constitutive nitric oxide synthase gene with myocardial infarction in Japanese population // Am. J. Cardiol. — 1998. — V. 81. P. 83−86.
- Iwai N., Ohmichi N., Nakamyra Y. et al. DD genotype of the angi-otensin-converting enzyme gene is a risk factor for left ventricular hypertrophy // Circulation. 1994. — V. 90. — P. 2622−2628.
- Iyer R.S., Singh G., Rebello S. et al. Changes in the concentration of endothelin 1 during development of hypertensive rats // Pharmacology — 1995. -V 51, № 2. — P. 96−104.
- Jalil J.E., Janicki J.S., Pick R. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle // Circ. Res. 1988. — V. 62. -P. 757−765.
- Jazayeri A, Meyer W. Mineralocorticoid induced increase in beta-adrenergic receptors of cultured rat arterial smooth muscle cells // J. Steroid Bio-chem. 1989. — V. 33. — P. 987−991.
- Jeunemaitre X., Lifton R.P., Hunt S.C. et al. Absence of linkage between the angiotensin-converting enzyme locus and human essential hypertension // Nat. Genet. 1992. — V. 1. — P. 72−75.
- Jin J.J., Nakura J., Wu Z. et al. Association of endothelin-1 gene variant with hypertension // Hypertension. 2003. — V. 41. — P. 163−167.
- Johns, M.B., Paulus-Thomas J.E. Purification of human genomic DNA from whole blood using proteinase K treatment followed by phenol-chlorophorm extraction //Anall. Biochem. 1989. -V. 180. — P. 276−278.
- Jones A., Dhamrait S.S., Payne J.R. et al. Genetic variants of angiotensin II receptors and cardiovascular risk in hypertension // Hypertension -2003. V. 42. — P. 500−506.
- Juvela S. Plasma endothelin concentrations after aneurismal subarachnoid hemorrhage // J. Neurosurg. 2000. — V. 92, № 3. — P. 390−400.
- Kainulainen K., Perola M., Terwilliger J. et al. Evidence for involvement of the type 1 angiotensin receptor locus in essential hypertension. // Hypertension. 1999. — 33. — P. 849−844.
- Kehoe P.G., Katzov H., Feuk L. Haplotypes extending across ACE are associated with Alzheimer’s disease // Human Molecular Genetics. — 2003. — V. 12.-P. 859−867.
- Kim S., Iwao H. Molecular and cellular mechanisms of angiotensin II mediated cardiovascular and renal diseases // Pharmacol Rev. 2000. -V. 52.-P. 11−34.
- Knox J.R., Lockett M.F. Similarity between a substance produced by the heart in vitro and the 18-monoacetyl derivative of D-aldosterone // J. Endocrinol. 1969. — V. 43. — P. 315−316.
- Kofford M.W., Schwartz L.B., Schechter N.M. et al. Cleavage of type I procollagen by human mast cell chymase initiates collagen fibril formation and generates a unique carboxyl-terminal propeptide // J. Biol. Chem. 1997. -V. 272.-P. 7127−7131.
- Komiya I., Yamada T., Takara M. et al. Lys 173Arg and -344T/C variants of CYP11B2 in japanese patients with low-renin hypertension // Hypertension. 2000. — V. 35. — P. 699−703.
- Krege J.H., Kim H.S., Moyer J.S. et al. Angiotensin-Converting enzyme gene mutations, blood pressure, and cardio-vascular homeostasis // Hypertension. 1997. -V. 29.-P. 150−157.
- Kunnas T.A., Ilveskoski E., Niskakangas T. et al. Association of the endothelial nitric oxide synthase gene polymorphism with risk of coronary artery disease and myocardial infarction in middle-aged men // J. Mol. Med. 2002 -V. 80. -P. 605−609.
- Kupari M, Koskinen P, Virolainen J: Correlates of left ventricular mass in a population sample aged 36 to 37 years // Circulation. 1994. -V. 89.-P. 1041−1050.
- Kupari M., Hautanen A., Lankinen L. et al. Associations between human aldosterone synthase (CYP11B2) gene polymorphisms and left ventricular size, mass, and function // Circulation. 1998. -V. 97. — P. 569−575.
- Lajemi M., Gautier S., Poirier O. et al. Endothelin Gene Variants and Aortic and Cardiac Structure in Never-Treated Hypertensives // Am. J. Hypertens. -2001.-V. 14.-P. 755−760.
- Lampl Y., Fleminger G., Gilard R et al. Endothelin in cerebrospinal fluid and plasma of patients in the early stage of ischemic stroke // Stroke 1997. — V. 28, № 10.-P. 1951−1955.
- Lander E.S. The new genomics: global views of biology // Science. -1996. -V. 274 (5287). P. 536−539.
- Lee W.H., Hwang T.H. et al. Genetic factors associated with endothelial dysfunction affect the early onset of coronary artery disease in Korean males // Vascular Medicine. 2001. — V. 6. — P. 103−108.
- Lefer D.J., Ma X.-L., Lefer A.M. Meth. Findings // Exp. Clin. Pharmacol. 1993. — V. 15. — P. 617−622.
- Lehmann D.J., Cortina-Borja M., Wardenl D.R. et al. Large metaanalysis establishes the ACE insertion-deletion polymorphism as a marker of Alzheimer’s Disease // Am. J. Epidemiol. 2005. — V. 162. — P. 305−317.
- Malik F.S., Lavie C.J., Mehra M.R. et al. Renin-angiotensin system: genes to bedside // Am. Heart. J. 1997. — V. 134. — P. 514−527.
- Mallamaci F., Zuccala A., Zoccali C. et al. The deletion polymorphism of the angiotensin-converting enzyme is associated with nephroangioscle-rosis // American Journal of Hypertension. 2000. — V. 13. — P. 433−437.
- Marsden P.A., Heng H.H., Scherer S.W. et al. Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene // J Biol Chem. 1993. — V. 268. — P. 17 478−17 488.
- Matsumoto T., Wada A., Tsutamoto T. et al. Chymase inhibition prevents cardiac fibrosis and improves diastolic dysfunction in the progression of heart failure // Circulation 2003. — V. 107 — P. 2555−2558.
- Mattei M.G., Hubert C., Alhenc-Gelas F. Angiotensin converting enzyme gene is on chromosome 17 // Cytogenet. Cell. Genet. 1989 — V. 51 -P. 1041.
- McMurray J., Ray S., Abdullah I. et al. Plasma endothelin in chronic heart failure // Circulation 1992. — V. 85. — P. 1374−1379.
- McNamara D. M., Tam W., Sabolinski M. L. et al. Aldosterone synthase promoter polymorphism predicts outcome in african americans with heart failure. Results from the A-HeFT trial // J. Am. Coll. Cardiol. 2006. — V. 48. -P.1277−1282.
- McNamara D.M., Holubkov R. Postava L. et al. Effect of the Asp298 variant of endothelial nitric oxide synthase on survival for patients with congestive heart failure // Circulation 2003. — V. 107. — P. 1598−1602.
- Mentlein R. Roos T. Proteases involved in the metabolism of angiotensin II, bradykinin, calcitonin gene-related peptide CGRP and neuropeptide Y by vascular smooth muscle cells // Atherosclerosis 2000. — V 152. — P. 271−285.
- Miller J.A., Thai K., Scholey J.W. Angiotensin II type 1 receptor gene polymorphism predicts response to lasartan and angiotensin II // Kidney Int. -1999. V. 56. — P. 2173−2180.
- Mitchel G.F. Pfeffer M.A. The role of geometry in left ventricular remodeling after myocardial infarction // Cardiol. Rev. 1995. — V. 3, № 2. -P. 71−78.
- Miyamoto Y., Saito Y., Kajiyama N. et al. Endothelial nitric oxide synthase gene is positively associated with essential hypertension // Hypertension 1998. — V. 32.-P. 3−8.
- Miyata S, Minobe W.A., Bristow M.R. et al. Myosin heavy chain isoform expression in the failing and non-failing human heart // Circ. Res. 2000. -V. 86.-P. 386−390.
- Miyauchi T, Yorikane R, Sakai S. et al. Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with mono-crotaline-induced pulmonary hypertension // Cir. Research. 1993. — V. 73 -P. 887−897.
- Monge J.C. Neurohormonal markers of clinical outcome incardiovas-cular disease: Is endothelin the best one? // J. Cardiovasc. Pharmacol. 1998. -32(suppl 2). — S36-S42.
- Murphy T.J., Alexander R.W., Griendling K.K. et al. Isolation of cDNA encoding the vascular type-1 angiotensin II receptor // Nature 1991. -V.351.-P. 233−236.
- Nagase S., Suzuki H., Wang Y. et al. Association of ecNOS gene polymorphisms with end stage renal diseases // Molecular and Cellular Biochemistry -2003.-V. 244.-P. 113−118.
- Nakahara K., Matsushita S., Matsuoka H. et al. Insertion/Deletion polymorphism in the angiotensin-converting enzyme gene affects heart weight // Circulation-2000.-V. 101.-P. 148−151.
- Nakauchi Y., Suehiro T., Yamamoto M. et al. Significance of angiotensin I-converting enzyme and angiotensin II type 1 receptor gene polymorphisms as risk for coronary heart disease // Atherosclerosis 1996. — V. 125. -P. 161−169.
- Nakayama N., Yasue H., Yoshimura M. et al. T786-C mutation in the 5'-flanking region of the endothelial nitric oxide synthase gene is associated with coronary spasm // Circulation 1999. — V. 99. — P. 2864−2870.
- Nambi P., Clozel M., Feuerstein G. Endothelin and Heart Failure // Heart Failure Reviews 2001. -V. 6. — P. 335−340.
- Narain Y., Yip A., Murphy T. The ACE gene and Alzheimer’s disease susceptibility // Journal of Medical Genetics. 2000. — V. 37. — P. 695−697.
- Neubauer S, Horn M, Naumann A et al. Myocardial phosphocreatine-to-ATP ratio is a predictor of mortality in patients with dilated cardiomyopathy // Circulation. 1997. -V. 96. — P. 2190−2196.
- Nickening G., Laufs U., Schnabel P. et al. Down-regulation of aortic and cardiac ATI receptor gene expression in transgenic (mRen-2)27 rats // Br. J. Pharmacol. 1997. -V. 121. — P. 134−140.
- Nicod J., Bruhin D., Auer L. et al. A biallelic gene polymorphism of CYP11B2 predicts increased aldosterone to renin ratio in selected hypertensive patients // J. Clin. Endocrinol. Metab. 2003. — V. 88. — P. 2495−2500.
- Ohmichi N., Iwai N., Uchida Y. Relationship between the response to the angiotensin converting enzyme inhibitor imidapril and the angiotensin converting genotype // Am. J. Hypertens. 1997. -V. 10. — P. 951−955.
- Omland T., Lie R., Aarsland T. et al. Plasma endothelin determination as a prognostic indicator of 1-year mortality after acute myocardial infarction // Circulation. 1994. — V. 89. — P. 1573−1579.
- Ortlepp J. R. Hanrath P. Mevissen V. et al. Variants of the CYP11B2 gene predict response to therapy with candesartan // European Journal of Pharmacology. 2002. — V. 445.-P. 151−152.
- Ortlepp J., Janssens U, Bleckmann F. et al. A chymase gene variant is associated with atherosclerosis in venous coronary artery bypass grafts // Coron. Artery Dis. 2001. — V. 12. — P. 493−497.
- Osterop A.P.R.M., Kofflard M.J.M., Sandkuijl L.A. et al. ATI receptor A/C1166 polymorphism contributes to cardiac hypertrophy in subjects with hypertrophic cardiomyopathy // Hypertension. 1998. — V. 32. — P. 825−830.
- Ott J. The Analysis of human genetic linkage // Baltimor. Johns Hopkins Press. 1991. -P. 223,
- Paillard F., Chansel D., Brand E. et al. Genotype-phenotype relationships for the renin-angiotensin-aldosterone system in a normal population // Hypertension. 1999. — V. 34. — P. 423−429.
- Palmieri E. A., Biondi B., Fazio S. Aldosterone receptor blockade in the management of heart failure // Heart Failure. 2002. — V. 7. — P. 205−219.
- Patel S., Steeds R., Channer K. et al. Analysis of promoter region polymorphism in the aldosterone synthase gene (CYP11B2) as a risk factor for myocardial infarction // Am. J. Hypertens. 2000. — V. 13. — P. 134−139.
- Paulus W.J., Vantrimpont P.J., Shah A.M. Acute effects of nitric oxide on left ventricular relaxation and diastolic distensibility in humans. Assessment by bicoronary sodium nitroprusside infusion // Circulation. 1994. — V. 89. -P. 2070−2078.
- Pepper C.B., Shah A.M. Nitric oxide: from laboratory to bedside // Spectrum Int. 1996. — V. 6, № 2. — P. 20−23.
- Perticone F., Ceravolo R., Cosco C. et al. Deletion Polymorphism of Angiotensin-Converting Enzyme Gene and Left Ventricular Hypertrophy in Southern Italian Patients // Journal of the American College of Cardiology -1997. V. 29, № 2. — P. 365−369.
- Pfeffer M. A., Braunwald E. Ventricular remodeling after myocardial infarction experimental observations and clinical implications // Circulation. -1990.-V81.-P. 1161−1172.
- Pfeufer A, Osterziel K-J., Urata H., et al. Angiotensin-converting enzyme and heart chymase gene polymorphisms in hypertrophic cardiomyopathy // Am. J. of Cardiol. 1996. -V. 78. — P. 362−364.
- Pfeufer A., Busjahn A., Vergopoulos A. et al. Chymase gene locus is not associated with myocardial infarction and is not linked to heart size or blood pressure // Am. J. of Cardiol. 1998. — V. 82. — P. 979−981.
- Pfohl M., Koch M., Prescod S. et al. Angiotensin I-converting enzyme gene polymorphism, coronary artery disease and myocardial infarction. An angiographically controlled study // European Heart Journal. 1999. -V. 20.-P. 1318−1325.
- Pieske B, Beyermann B, Breu V. et al. Functional effects of endothe-lin and regulation of endothelin responses in isolated nonfailing myocardium // Circulation. 1999. -V. 99. — P. 1802−1809.
- Pojoga L., Gautier S., Blanc H. et al. Genetic determination of plasma aldosterone levels in essential hypertension // Am. Journal of Hypertension -1998. V. 11, № 7. — P. 856−860.
- Pool P.E., Spann J.F., Buccino R.A. et al. Myocardial high energy phosphate stores in cardiac hypertrophy and heart failure // Circ. Res. 1967. -V.21.-P. 365−373.
- Raynolds M.V., Bristow M.R., Bush E.W. et al. Angiotensinconverting enzyme DD genotype in patients with ischaemic or idiopathic dilated cardiomyopathy // Lancet. 1993. — V. 342 (8879). — P. 1073−1075 (abstract).
- Redmond E.M., Cahill P. A., Hodges R. et al. Regulation of endothelin receptors by nitric oxide in cultured rat vascular smooth muscle cells // J. Cell. Physiol. 1996. -V. 166. — P. 469179.
- Rees D.D., Palmer R.M.J., Moncada S. Role of endothelium-derived nitric oxide in the regulation of blood pressure // Proc. Natl. Acad. Sei. USA. -1989. V. 86. — P. 3375−3378.
- Reich D.E., Lander E.S. On the allelic spectrum of human disease // Trends Genet. 2001. — V. 17, № 9. — P. 502−510.
- Rice G.I., Foy C.A., Grant P.J. Angiotensin converting enzyme and angiotensin II type 1 receptor gene polymorphisms and risk of ischaemic heart disease // Cardiovasc. Res. 1999. — V. 41. — P. 746−753.
- Rigat B., Hubert C., Corvol P., Soubreir F. PCR detection of the insertion/deletion polymorphism of the angiotensin converting enzyme gene (DCP1) (depeptidyl-carboxypeptidase 1) // Nucl Acids. Res. 1992. — V. 20. — P. 1433.
- Rish N., Zhang H. Extreme discordant sib pairs for mapping quantitative trait loci in humans. // Science. 1995. — V. 268. — P. 1584−1589.
- Rothermund L., Paul M. Hypertension and the rennin-angiotensin system evidence from genetic and transgenic studies // Basic Res. Cardiol. — 1998. -V. 93 — P. 1−6.
- Rychlik, W. Optimization of the annealing temperature for DNA amplification in vitro // Nucleic Acids Research. 1990. — V. 18, № 21. -P. 6409−6412.
- Saarinen J., Kalkkinen N., Welgus H.G. et al. Activation of human interstitial procollagenase through direct cleavage of the Leu83-Thr84 bond by mast cell chymase // J. Biol. Chem. 1994. — V. 269, № 27. — P. 18 134−14 140.
- Sabbah H.N. Apoptotic cell death in heart failure // Cardiovasc. Res. -2000.-V. 45.-P. 704−712.
- Sakai S., Miyauchi T., Kobayashi M. et al. Inhibition of myocardial endothelin pathway improves long-term survival in heart failure // Nature 1996. -V. 384.-P.'353−355.
- Sanderson J.E., Yu C.M., Young R.P. et al. Influence of gene polymorphisms of the renin-angiotensin system on clinical outcome in heart failure among the Chinese // Am. Heart Journal. 1999. — V. 137(4 Pt 1). — P. 653−657.
- Schlesselman, J. Case-control studies. Design, conduct, analysis // Oxford: Oxford Univ. Press. 1982. — P. 350.
- Schmidt S., Van Hooft I.M.S., Grobbee D.E. et al. Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study. // J. hypertens. 1993- 11:345−348.
- Schunkert H., Hengstenberg Ch., Holmer S. R. et al. Lack of association between a polymorphism of the aldosterone synthase gene and left ventricular structure // Circulation. 1999. — V. 99. — P. 2255−2260.
- Schunkert H., Hense H.W., Holmer S.R. et al. Association between a deletion polymorphism of the angiotensin-converting enzyme gene and left ventricular hypertrophy // N. Engl. J. Med. 1994. — V. 330. — P. 1634−1638.
- Schuta A.F.C., Bleuminka G.S., Strickera B.H.Ch. et al. Angiotensin converting enzyme insertion/deletion polymorphism and the risk of heart failure in hypertensive subjects // European Heart Journal 2004 — V 25 — P. 2143−2148
- Schwinger R.H.G., Munch G, Bolck B et al. Reduced Ca2±sensitivity of SERCA 2a in failing human myocardium due to reduced serinel6 phospholamban phosphorylation // J. Mol. Cell. Cardiol. 1999. — V. 31 -P. 479−491.
- Serrano N.C., Casas J.P., Diaz L.A. et al. Endothelial NO Synthase Genotype and Risk of Preeclampsia. A Multicenter Case-Control Study // Hypertension 2004. — V. 44. — P. 702−707.
- Sharif I., Kane K.A., Wainwright C.L. Endothelin and ischaemic arr-hythmias-antiarrhythmic or arrhythmogenic? // Cardiovasc. Res. 1998. -V. 39, № 3.-P. 625−632.
- Shimasaki Y, Yasue-H, Yoshimura M et al. Association between the Glu298Asp mutation of the nitric oxide synthase gene and myocardial infarction in the Japanese // Circulation. 1996. — V. 94. (suppl I) -1−596. (abstract).
- Siani A., Russo P., Cappuccio F. P. et al. Combination of renin-angiotensin system polymorphisms is associated with altered renal sodium handling and hypertension // Hypertension 2004 — V. 43 — P. 598−602.
- Silvestre J.S., Robert V., Heymes C. et al. Myocardial production of aldosterone and corticosterone in the rat. Physiological regulation // J. Biol. Chem. 1998. — V. 273. — P. 4883−4891.
- Sneddon J.M., Vane J.R. Endothelium-derived relaxing factor reduces platelet adhesion to bovine endothelial cells // Proc. Natl. Acad. Sci. USA. -1988. V. 85. — P. 2800−2804.
- Stella P., Bigatti G., Tizzoni L. et al. Association between aldosterone synthase (CYP11B2) polymorphism and left ventricular mass in human essential hypertension // J. Am.Coll. Cardiol. 2004. — V. 43. — P. 65−70.
- Sutton M. St. J., Lee D., Rouleau J. L. et. al. Left ventricular remodeling and ventricular arrhythmias after myocardial infarction // Circulation — 2003. -V. 107.-P. 2577−2582.
- Suzuki M., Ohte N., Wang Z. et al. Altered inotropic response of ET-1 in cardiomyocytes from rats with isoproterenol induced cardiomyopathy // Cardiovasc. Res. — 1998. — V. 39, № 3. — P. 589−599.
- Szokodi I., Horkay F., Merkely B et al. Intrapericardial infusion of en-dothelin 1 induces ventricular arrhythmias in dog // Cardiovasc. Res. — 1998. -V. 38, № 2.-P. 356−364.
- Takai E., Akita H., Kanazawa K. et al. Association between aldosterone synthase (CYP11B2) gene polymorphism and left ventricular volume in patients with dilated cardiomyopathy // Heart. 2002. — V. 88. — P. 649−650.
- Takai S., Shiota N., Jin D., Miyazaki M. Functional role of chymase in angiotensin II formation in human vascular tissue // J. Cardiovasc. Pharmacol. -1998. V. 32, № 5. — P. 826−833.
- Takami S., Imai Y., Katsuya T. et al. Gene polymorphism of rennin-angiotensin system associates with risk for lacunar infarctions: the Ohasama Study // Am. J. Hypertens. 2000. — V. 13. — P. 121−127.
- Takami S., Katsuya T., Rakugi H. et al. Angiotensin II type 1 receptor gene polymorphism is associated with increase of left ventricular mass but not with hypertension // Am. J. Hypertens. 1998. -V. 11. — P. 316−321.
- Takeda Y, Miyamori I, Yoneda T et al. Regulation of aldosterone synthase in human vascular endothelial cells by angiotensin II and adrenocortico-tropin // J. Clin. Endocrinol. Metab. 1996. — Y. 81. — P. 2797−2800.
- Takeda Y, Miyamori I, Yoneda T. et al. Production of aldosterone in isolated rat blood vessels // Hypertension. 1995. — V. 25. — P. 170−173.
- Takeda Y, Yoneda T, Demura M. et al. Sodium-induced cardiac aldosterone synthesis causes cardiac hypertrophy // Endocrinology. — 2000. -V. 141, № 5.-P. 1901−1904.
- Tamaki Sh., Iwai N., Tsujita Y. et al. Genetic polymorphism of CYP11B2 gene and hypertension in Japanese // Hypertension. 1999. — V. 33. [part II]. -P. 266−270.
- Tanaka M., Ito H., Adachi S. et. al. Hypoxia induces apoptosis with enhanced expression of Fas antigen messenger RNA in cultures neonatal rat cardiomyocytes // Circ. Res. 1994. — V. 75. — P. 426133.
- Testa M., Yeh M., Lee P. et al. Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive failuredue to coronary artery disease or hypertension // J.Am.Coll.Cardiol. 1996. — V. 28.-P. 964−971.
- Thomas W.G. Regulation of angiotensin II type 1 (ATI) receptor function // Regul. Peptides. 1999. — V. 79. — P. 9−23.
- Tiago A. D, Badenhorst D., Skudicky D. et al. An aldosterone synthase gene variant is associated with improvement in left ventricular ejection fraction in dilated cardiomyopathy // Cardiovasc. Res. 2002. — V. 54, № 3. — P. 584−589. (abstract).
- Tiret L, Rigat B, Visvikis S. et al. Evidence from combined segregation and linkage analysis, that a variant of the angiotensin I-converting enzyme (ACE) gene controls plasma ACE levels // Am. J. Hum. Genet. 1992. — V. 51. -P.197−205.
- Tiret L., Bonnardeaux A., Poirier O. et al. Synergistic effects of an-giotensin-converting enzyme and angiotensin-II type 1 receptor gene polymorphisms on risk of myocardial infarction // Lancet. 1994. — V. 344. (8927). -P. 910−913.
- Tiret L., Mallet Ch., Poirier O. et al. for the cardigene group. Lack of association between polymorphisms of eight candidate genes and idiopathic dilated cardiomyopathy. The CARDIGENE Study // J. Am. Coll. Cardiol. 2000. -V.35.-P. 29−35.
- Tiret L., Poirier O., Hallet V. et al. The Lysl98Asn polymorphism in the endothelin-1 gene is associated with blood pressure in overweight people // Hypertension. 1999. — V. 33. — P. 1169−1174.
- Tsukada T., Yokoyama K., Arai T. et al. Evidence of association of the ecNOS gene polymorphism with plasma NO metabolite level in humans // Bi-ochem. Biophys. Res. Commun. 1998. — V. 245. — P. 190−193.
- Tuinenburg A.E., Vanveldhusen D.J., Boomsma F. et al. Comparison of plasma neurohormones in congestive heart failure patients with atrial fibrillation versus patients with sinus rhythm // Am. J. Cardiol. 1998. — V. 81, № 10. -P.1207−1212.
- Ullian M.E., Hutchison F.N., Hazen-Martin D.J. et al. Angiotensin II-aldosterone interaction on protein synthesis in vascular smooth muscle cells // Am. J. Physiol. 1993 -V. 264. — P. C1525-C1531.
- Umans J.G., Levi R. Nitric oxide in the regulation of blood flow and arterial pressure // Ann. Rev. Physiol. 1995. — V. 57. — P. 771−790.
- Voetsch B., Loscalzo J., Genetic determinants of arterial thrombosis // Arterioscler. Thromb. Vase. Biol. 2004. — V. 24. — P. 216−229.
- Wang Ji-Guang, Staessen J.A. Genetic polymorphisms in the renin-angiotensin system: relevance for susceptibility to cardiovascular disease // European Journal of Pharmacology. 2000. — V. 410. — P. 289−302.
- Wang X.L., Mahaney M.C., Sim A. S et al. Genetic contribution of the endothelial constitutive nitric oxide synthase gene to plasma nitric oxide levels // Arterioscler. Thromb. Vase. Biol. 1997. — V. 17. — P. 3147−3153.
- Wang X.L., Sim A.S., Badenhop R.F. et al. A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene // Nat. Med. 1996. — V. 2. — P. 41−45.
- Wang X.L., Wang J. Endothelial nitric oxide synthase gene sequence variations and vascular disease // Mol. Gen. Metab. 2000. — V. 70. -P. 241−251.
- Wang Y., Kikuchi Sh., Suzuki H. et al. Endothelial nitric oxide synthase gene polymorphism in intron 4 affects the progression of renal failure in non-diabetic renal disease // Nephrol. Dial. Transplant. 1999. — V. 14. -P. 2898−2902.
- Wang Y., Marsden P.A. Nitric oxide synthases: biochemical and molecular regulation // Curr. Opin. Nephrol. Hypertens. 1995. — V. 4. — P. 12−22.
- Weber K.T. (Ed). The heart’s extracellular matrix. // Cardiovasc. Res. -2000-V 46-P. 211−355.
- Weber K.T., Janicki J.S., Pick R. et al. Myocardial fibrosis and pathologic hypertrophy in the rat with renovascular hypertension // Am. J. Cardiol. -1990-V. 65 1G-7G.
- Weber K.T., Purdy R.E., Drayer J.I.M. Interactions between aldosterone and pressor agents in vascular smooth muscle // Hypertension. 1983. -(2 Pt 2) — P. 141−146.
- Weber KT. Cardiac interstitium in health and disease: the fibrillar collagen network // J. Am. Coll. Cardiol. 1989. — V. 13. — P. 1637−1652.
- Weiss K.M., Terwilliger J.D. How many diseases does it take to map a gene with SNPs? // Nat. Genet. 2000. — V. 26, № 2. — P. 151−157.
- Wright A.F., Hastie N.D. Complex genetic diseases: controversy over the Croesus code // Genome Biol. 2001. 8(2) P. COMMENT 2007.274. (http://genomebiology.com/200 l/2/8/comment/2007).
- Yasue H, Yoshimura M, Sugiyama S et al. Association of a point mutation of the endothelial cell nitric oxide synthase gene with coronary spasm // Circulation 1995. — V. 92(suppl I) — P. 1−363. (abstract).
- Ylitalo A., Airaksinen J., Hautanen A. et al. Baroreflex Sensitivity and Variants of the Renin Angiotensin System Genes // J.Am. Coll. Cardiol. -2000.-V. 35.-P. 194−200.
- Yoon Y, Song J, Hong S.H. et al. Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease // Clin. Chem. 2000. — V. 46.-P. 1626−1630.
- Yorikane R., Sakai S., Miyauchi T. et al. Increased production of en-dothelin-1 in the hypertrophied rat heart due to pressure overload // FEBS Lett. -1993.-V. 332.-P. 31−34.
- Yousef Z. R., Redwood S., R., Marber M. S. Postinfarction left ventricular remodelling: where are the theories and trials leading us? // Heart. — 2000. -V. 83.-P. 76−80.
- Zee R.Y.L., Rao V.S., Paster R.Z. et al. Three candidate genes and angiotensin converting enzyme inhibitor-related cough // Hypertension. 1998. -V. 31.-P. 925−928.
- Zhang X., Erdman J., Regitz-Zagrosek V. et al. Evaluation of three polymorphisms in the promotor region of the region of the angiotensin II type 1 receptor gene // J. Hypertens. — V. 18. 267−272.
- Zimmerman M., Seifert V. Endothelin and subarachnoid hemorrhage: An overview // Neurosurgery. 1998. — V. 43, № 4 p. 863−875.
- Zolk O., Quattek J., Sitzler G. et al. Expression of endothelin-1, en-dothelin-converting enzyme, and endothelin receptors in chronic heart failure // Circulation. 1999. — V. 99. — P. 2118−2123.